Articles published in Journal of Bioanalysis & Biomedicine have been cited by esteemed scholars and scientists all around the world.
Journal of Bioanalysis & Biomedicine has got h-index 24, which means every article in Journal of Bioanalysis & Biomedicine has got 24 average citations.
Following are the list of articles that have cited the articles published in Journal of Bioanalysis & Biomedicine.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|
Total published articles |
60 | 37 | 59 | 59 | 24 | 10 | 31 |
Research, Review articles and Editorials |
4 | 11 | 6 | 8 | 5 | 8 | 19 |
Research communications, Review communications, Editorial communications, Case reports and Commentary |
16 | 26 | 53 | 51 | 19 | 2 | 12 |
Conference proceedings |
8 | 13 | 0 | 0 | 0 | 35 | 92 |
Citations received as per Google Scholar, other indexing platforms and portals |
233 | 247 | 335 | 339 | 358 | 330 | 290 |
| Journal total citations count | 3099 |
| Journal impact factor | 1.8 |
| Journal 5 years impact factor | 7.67 |
| Journal cite score | 7.38 |
| Journal h-index | 24 |
| Journal h-index since 2019 | 19 |
Kongkham, Bhani, Duraivadivel Prabakaran, and Hariprasad Puttaswamy. "Opportunities and challenges in managing antibiotic resistance in bacteria using plant secondary metabolites." Fitoterapia (2020): 104762. |
|
Abedon, Stephen T. "Phage-phage, phage-bacteria, and phage-environment communication." In Biocommunication of Phages, pp. 23-70. Springer, Cham, 2020. |
|
Danis-Wlodarczyk, Katarzyna, Krystyna D?browska, and Stephen T. Abedon. "Phage therapy: the pharmacology of antibacterial viruses." Current Issues in Molecular Biology 40, no. 1 (2020): 81-164. |
|
Manohar, Prasanth, Ashok J. Tamhankar, Sebastian Leptihn, and Nachimuthu Ramesh. "Pharmacological and immunological aspects of phage therapy." Infectious Microbes & Diseases 1, no. 2 (2019): 34-42. |
|
Nishant, T., H. K. Bindu, S. D. Kumar, and A. R. Kumar. "Pharmacogenomics-Personalized treatment of cancer, diabetes and cardiovascular diseases." J Pharmacogenom Pharmacoproteomics 3, no. 107 (2012): 2153-0645. |
|
Brown, Teagan L., Tereen Thomas, Jessica Odgers, Steve Petrovski, Marion Joy Spark, and Joseph Tucci. "Bacteriophage formulated into a range of semisolid and solid dosage forms maintain lytic capacity against isolated cutaneous and opportunistic oral bacteria." Journal of Pharmacy and Pharmacology 69, no. 3 (2017): 244-253. |
|
Abedon, Stephen T. "Active bacteriophage biocontrol and therapy on sub-millimeter scales towards removal of unwanted bacteria from foods and microbiomes." AIMS microbiology 3, no. 3 (2017): 649. |
|
Nho, Seong-Won, Mi-Ae Ha, Ki-Sei Kim, Tae-Hwan Kim, Ho-Bin Jang, In-Seok Cha, Seong-Bin Park, Young-Kyu Kim, and Tae-Sung Jung. "Complete genome sequence of the bacteriophages ECBP1 and ECBP2 isolated from two different Escherichia coli strains." (2012): 12439-12440. |
|
Forde, Amanda, and Colin Hill. "Phages of life–the path to pharma." British journal of pharmacology 175, no. 3 (2018): 412-418. |
|
Abedon, Stephen T. "Use of phage therapy to treat long-standing, persistent, or chronic bacterial infections." Advanced drug delivery reviews 145 (2019): 18-39. |
|
Onsea, Jolien, Patrick Soentjens, Sarah Djebara, Maia Merabishvili, Melissa Depypere, Isabel Spriet, Paul De Munter et al. "Bacteriophage application for difficult-to-treat musculoskeletal infections: development of a standardized multidisciplinary treatment protocol." Viruses 11, no. 10 (2019): 891. |
|
Hyman, Paul, and Stephen T. Abedon. "Smaller fleas: viruses of microorganisms." Scientifica 2012 (2012). |
|
Tsonos, Jessica, Dieter Vandenheuvel, Yves Briers, Henri De Greve, Jean-Pierre Hernalsteens, and Rob Lavigne. "Hurdles in bacteriophage therapy: deconstructing the parameters." Veterinary microbiology 171, no. 3-4 (2014): 460-469. |
|
Abedon, Stephen T. "Bacteriophage clinical use as antibacterial “drugs”: utility and precedent." Bugs as Drugs: Therapeutic Microbes for the Prevention and Treatment of Disease (2018): 417-451. |
|
Abedon, Stephen T. "Phage-antibiotic combination treatments: antagonistic impacts of antibiotics on the pharmacodynamics of phage therapy?." Antibiotics 8, no. 4 (2019): 182. |
|
El Haddad, Lynn, Cynthia P. Harb, Marc A. Gebara, Mark A. Stibich, and Roy F. Chemaly. "A systematic and critical review of bacteriophage therapy against multidrug-resistant ESKAPE organisms in humans." Clinical Infectious Diseases 69, no. 1 (2019): 167-178. |
|
Abedon, Stephen T. "Phage therapy: eco-physiological pharmacology." Scientifica 2014 (2014). |
|
Abedon, Stephen T. "Ecology of anti-biofilm agents I: antibiotics versus bacteriophages." Pharmaceuticals 8, no. 3 (2015): 525-558. |
|
Leung, Sharon SY, Thaigarajan Parumasivam, Fiona G. Gao, Nicholas B. Carrigy, Reinhard Vehring, Warren H. Finlay, Sandra Morales, Warwick J. Britton, Elizabeth Kutter, and Hak-Kim Chan. "Production of inhalation phage powders using spray freeze drying and spray drying techniques for treatment of respiratory infections." Pharmaceutical research 33, no. 6 (2016): 1486-1496. |
|
Abedon, Stephen T. "Ecology of anti-biofilm agents II: bacteriophage exploitation and biocontrol of biofilm bacteria." Pharmaceuticals 8, no. 3 (2015): 559-589. |
|
Journal of Bioanalysis & Biomedicine received 3099 citations as per Google Scholar report
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 